Added 4 months ago Drug news
Surufatinib in advanced neuroendocrine tumors – extra-pancreatic,met the primary endpoint of progression free survival
Hutchison China MediTech announced that the independent Data Monitoring Committee of the Phase III pivotal study of surufatinib in advanced...
Added 9 months ago Drug news
Merck Inc., announced that the FDA has approved Keytruda, Merck’s anti-PD-1 therapy, for the treatment of adult and pediatric patients...
Added 1 year ago Drug news
Novartis announced presentation of a new analysis of Lutathera (lutetium Lu 177 dotatate) NETTER-1 data examining the impact of Lutathera...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
What are biologics and how do they differ from small molecule medicines? Discover more about their development, as well as the manufacturing and regulatory processes in the Biosimilars in Oncology Knowledge Centre.
The CDK 4/6 Inhibitors in Metastatic Breast Cancer Learning Zone provides insights and information for metastatic breast cancer (mBC) and CDK 4/6 signalling. This includes the burden and pathophysiology of the disease, the role of CDK 4/6 in cell proliferation and an overview of the CDK 4/6 inhibitors that have been approved for the management of mBC.
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.
Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.
Background: Liver transplantation to treat neuroendocrine tumors, especially in the setting of diffuse liver involvement not amenable to operative resection remains controversial. We sought to perform a systematic review...
Added 1 year ago
Evaluation of Lanreotide Depot/Autogel efficacy and safety as a carcinoid syndrome treatment (ELECT): a randomized, double-blind, placebo-controlled trial.
Objective: To evaluate the efficacy and safety of lanreotide depot/autogel 120mg for the control of carcinoid syndrome (CS) symptoms in...
Added 3 years ago
Carcinoma of unknown primary origin: diagnosis and management: putting NICE guidelines into practice
- Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
- Credits available
- Registration required
- Subscription fee